The Dorsalization of Spermann's Organizer Takes Place during Gastrulation in Xenopus laevis Embryos
Open Access
- 1 February 1993
- journal article
- Published by Wiley in Development, Growth & Differentiation
- Vol. 35 (1) , 25-32
- https://doi.org/10.1111/j.1440-169x.1993.00025.x
Abstract
Suramin, a polyanionic compound, which is thought to inhibit the binding of growth factors to their receptors, prevents the differentiation of the dorsal blastopore lip of early gastrulae into dorsal mesodermal structures as notochord and somites. Suramin treated blastopore lips form ventral mesodermal structures, mainly heart structures. Several cases showed rythmic contractions (“beating hearts”). Of special interest is the fact that blastopore lips isolated from middle gastrulae followed by suramin treatment differentiate in about 50% of the cases brain structures without the presence of notochord. These data suggest that suramin prevents the differentiation of the dorsal blastopore lip into notochord up to the early middle gastrula stage but no longer the formation of head mesoderm, which is the prequisite for the induction of archencephalic brain structures. Treated chordamesoderm with overlaying ectoderm from late gastrulae will differentiate as untreated controls, namely into dorsal axial structures like notochord, somites and brain structures. The results indicate that primarily a more general or ventral mesodermal signal is transferred from the dorsal vegetal blastomeres (Nieuwkoop center) to the dorsal marginal zone. The dorsalization, which enables the blastopore lip to differentiate into head mesoderm and notochord and in turn to acquire neuralizing activity, takes place during the early steps of gastrulation.Keywords
This publication has 26 references indexed in Scilit:
- Spatial and temporal localization of FGF receptors in Xenopus laevisWilhelm Roux' Archiv für Entwicklungsmechanik der Organismen, 1992
- Pleiotropic actions of suramin on the proliferation of human breast-cancer cellsin vitroInternational Journal of Cancer, 1992
- Inhibitory Effects of Suramin on a Human Renal Cell Carcinoma Line, Causing Nephrogenic Hepatic DysfunctionJournal of Urology, 1992
- A novel, activin-inducible, blastopore lip-specific gene of Xenopus laevis contains a fork head DNA-binding domain.Genes & Development, 1992
- Suramin Inhibits Gonadotropin Action In Rat Testis: Implications For Treatment Of Advanced Prostate CancerJournal of Urology, 1992
- Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cellsJournal of Cellular Physiology, 1992
- Suramin, an Active Nonhormonal Cytotoxic Drug for Treatment of Prostate Cancer: Compelling Reasons for Testing in Patients With Hormone-Refractory Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoidCell, 1991
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.Proceedings of the National Academy of Sciences, 1986